Keyphrases
Heart Failure
100%
Angiotensin-converting Enzyme Inhibitor (ACEi)
60%
Clinical Trials
40%
Myocardial Infarction
40%
Left Ventricular Dysfunction
40%
Angiotensin Receptor Blockers
40%
Candesartan
40%
Acute Decompensated Heart Failure
20%
Evidence-based
20%
Chronic Heart Failure
20%
Pharmacotherapy
20%
Beta-blockers
20%
Valsartan
20%
Hypotension
20%
Initial Treatment
20%
Patients with Heart Failure
20%
Clinical Evidence
20%
Evidence-based Medicine
20%
Renin-angiotensin-aldosterone System
20%
Hyperkalemia
20%
Sympathetic Nervous System
20%
Cardiovascular Effects
20%
Survival Benefit
20%
Incremental Benefits
20%
Neuroendocrine Response
20%
Renal Insufficiency
20%
Close Follow-up
20%
Biologically Plausible
20%
Eplerenone
20%
Spironolactone
20%
Aldosterone Antagonists
20%
Pharmacology, Toxicology and Pharmaceutical Science
Congestive Heart Failure
100%
Dipeptidyl Carboxypeptidase Inhibitor
37%
Clinical Trial
25%
Heart Infarction
25%
Angiotensin Receptor Antagonist
25%
Heart Left Ventricle Failure
25%
Candesartan
25%
Pharmacotherapy
12%
Aldosterone Antagonist
12%
Beta Adrenergic Receptor Blocking Agent
12%
Hyperkalemia
12%
Hypotension
12%
Kidney Failure
12%
Eplerenone
12%
Spironolactone
12%
Aldosterone
12%
Renin
12%
Angiotensin
12%
Valsartan
12%
Side Effect
12%